KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Shares Issued (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Shares Issued for 12 consecutive years, with $60.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Issued rose 404.13% to $60.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $60.0 million, a N/A change, with the full-year FY2024 number at $60.0 million, changed N/A from a year prior.
  • Shares Issued was $60.0 million for Q4 2024 at Palvella Therapeutics, up from -$19.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $60.0 million in Q4 2024 to a low of -$19.7 million in Q4 2023.
  • A 5-year average of $5.6 million and a median of $77000.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 611.03% in 2021, then skyrocketed 9794.2% in 2022.
  • Palvella Therapeutics' Shares Issued stood at -$145000.0 in 2020, then surged by 147.59% to $69000.0 in 2021, then surged by 9794.2% to $6.8 million in 2022, then plummeted by 388.98% to -$19.7 million in 2023, then soared by 404.13% to $60.0 million in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Shares Issued are $60.0 million (Q4 2024), -$19.7 million (Q4 2023), and $19.7 million (Q3 2023).